*Medical surveillance terminology is currently used in occupational health and safety standards. However, AAOHN recommends use of the term "health surveillance" to more accurately reflect the purpose of surveillance (health promotion/early disease detection) and the wider range of health professionals who conduct surveillance programs. JULY 1998, VOL. 46, NO.7 sure is acute or chronic, recent or remote, high or low.
An indirect measure of exposure and a physiologic marker for the biologically harmful effects of lead is erythrocyte protoporphyrin (EP) or zinc protoporphyrin (ZPP) . An increase indicates that lead is affecting the heme synthesis pathway. This effect can begin at a BLL as low as 20 ug/dl, in some adults, but the test is not >90% sensitive until blood lead concentration exceeds 50 fLg/dL. An elevation in EP or ZPP usually lags an increase in BLL by 2 to 6 weeks. Therefore, a normal EP or ZPP in the presence of an elevated BLL suggests recent exposure. Other health conditions can cause an elevated EP or ZPP, the most common iron deficiency anemia and inflammatory conditions (Froom, 1996; National Committee for Clinical Laboratory Standards, 1996) . Generally, screening for other causes is recommended if the EP or ZPP is >50 fLg/dL and the BLL is below the threshold of heme effect.
Periodic testing of BLL and ZPP is called biological monitoring. These tests provide valuable information to assess lead exposure for individuals as well as groups of workers. A detailed exposure history is an essential part of evaluating and interpreting biological monitoring information.
Lead adversely affects several body systems. Clinically, the most sensitive are the nervous, hematopoietic, gastrointestinal, cardiovascular, musculoskeletal, renal, and reproductive systems. Wide variation exists in individual susceptibility to lead poisoning. Symptoms begin in some people with a BLL of 25 ug/dl, (Kosnett, 1994a) . In general, the number and severity of symptoms worsen with increasing BLL (Table 1) .
Early symptoms are often subtle and nonspecific, involving the nervous system (listlessness, fatigue, irritability, sleep disturbance, headache, difficulty concentrating, decreased libido), the gastrointestinal system (abdominal cramps, anorexia, nausea, constipation, diarrhea) or the musculoskeletal system (arthralgia, myalgia) . A high level of intoxication can result in delirium, seizures, and coma associated with lead encephalopathy, a life threatening situation.
Research shows multiple health effects at levels once believed safe. Several epidemiologic investigations and animal studies suggest lead may elevate blood pressure in susceptible adults at blood lead concentrations as low as 14 ug/dl, (Harlan, 1988; Schwartz, 1988) . A recent study of 590 men aged 48 to 92 years, with predominately nonoccupational lead exposure and a mean BLL concentration of 6.3 ug/dl., found increases in bone lead concentration were associated with an increased risk of hypertension . Because hypertension is a significant risk factor for heart disease, lead exposure may exert an important influence on cardiovascular mortality.
Early kidney damage is difficult to detect. Recent epidemiologic studies have linked low levels of lead exposure to decrements in renal function. A 10 u.g/dl, increase in BLL has been associated with a 10.4 mL/minute decrease in renal creatinine clearance rate among a population with an average BLL of 8.1 ug/dl, . In a population of older men with mean 
Severe Toxicity
Colic (intermittent, severe abdominal cramps)
Peripheral neuropathy

Convuls ions
Encephalopathy BLL concentration of 8.6 IJ-g/dL (range, 0.2 -54.1), a 10 fold increase in BLL predicted an increase of 0.08 mg/dL in serum creatinine concentration, roughly equivalent to 20 years of aging (Kim, 1996) . The extent to which these blood lead increases are a cause of decreased renal function, rather than a result of subclinical renal insufficiency, is not fully known. Subclinical slowing of nerve conduction velocity has been seen at BLLs as low as 30 IJ-g/dL (Seppalainen, 1983) . Neurops ychological studies performed in workers with blood lead concentrations in the 30 to 50+ IJ-g/dL range have detected subtle adverse effects on reaction time, visual-motor coordination, and mood (Baker, 1985; Campara, 1984; Mantere, 1984; Stollery, 1996) . Lead and other heavy metals may be slow to enter and leave the brain tissue. Consequently, central nervous system effects may have a delayed onset and sometimes persist well after the BLL has dropped below the action levels required by the lead standards. These effects may negatively impact job perform ance and safety.
Frank anemia usually does not occur until BLLs are > 50 to 60 IJ-g/dL. However, in individuals without frank anemia, bone lead levels were significantly correlated 332 with a decrease in hemoglobin and hematocrit even though BLLs were low (mean 8.3 IJ-g/dL). This may reflect a subclinical effect of bone lead stores on hematopoiesis .
In male s, abnormal sperm morphology and decreased sperm count have been observed at approximately 40 IJ-g/dL (Alexander, 1996; Lerda, 1992) . In females, lead readily crosses the placenta and is present in breast milk (Abadin, 1997) . Impaired cognitive development has been observed in children with prenatal lead exposure (Bellinger, 1987) . Evidence suggests this effect is enhanced by postnatal, low level, environmental lead exposure (Bellinger, 1990) . The persistence of this effect is still uncertain (Bellinger, 1992) .
Household members of workers with lead exposure are at increased risk for lead poisoning if lead is carried home on the worker' s body, clothes, shoes, or in the personal vehicle (called "take home" exposure). Employers risk civil liability for health damage to household members caused by an improperly protected worker who takes lead home. Children under 6 years old and a developing fetus are especially sensitive to neurologic damage. Available evidence suggests there is no BLL without risk of health effects in these populations (National Research Council, 1993) .
THE OSHA LEAD STANDARDS
The 1978 federal OSHA general industry lead standard was adopted to reduce workplace exposures and to prevent frank lead poisoning through early identification of elevated BLLs. In 1993, federal OSHA adopted a similar lead standard for the construction industry. Individual states may adopt lead standards at least as stringent as the federal standards. The lead standards are comprehensive and explain the employer's responsibilities to lead exposed employees including medical surveillance requirements ( Table 2 ). Additional information for clinicians is contained in Appendix C of both standards (copies can be obtained from the OSHA web site: http://www.osha.gov).
The standards require employers to assess employee exposure to lead, control exposures (through use of engineering controls, choice of work method, hygiene and housekeeping procedures, and respiratory protection), train employees, and establish an ongoing medical/health surveillance program. Employers are required to pay for all medical monitoring and to continue to pay the salary and benefits of employees removed from work for health reasons related to lead exposure. Employers are also required to use a licensed physician to supervise the lead medical!health surveillance program.
Physicians in a stated or unstated contractual arrangement with an employer need to know their duties to the employer and employees under the lead standards and be cognizant of any potential legal liabilities that may arise from this relationship (Table 3) . Physicians may unknowingly find themselves in this role either as a consultant to a laboratory that tests blood lead levels or as the de facto health care provider for a company. The lead standards should be consulted prior to implementing a medical surveillance program. 
ROLE OF THE OCCUPATIONAL AND ENVIRONMENTAL HEALTH NURSE
Occupational and environmental health nurses are in strategic positions to advocate for appropriate lead prevention policies (Lusk, 1995) . Whether working in a lead using plant, an occupational or primary care clinic, or providing consultation services for lead using businesses, nurses can help identify workers at risk and prevent lead poisoning by education and early intervention. This can be accomplished by working collaboratively with the workers, the employer, the company's medical supervisor, and other health and safety professionals. In conjunction with carrying out the medical surveillance requirements of the OSHA lead standards, it is important to establish written policies and protocols consistent with laws governing nursing practice and clearly outline the roles and responsibilities of the nurse and the medical supervisor.
Lead exposed workers are frequently employed by small companies. Thus, occupational and environmental health nurses may not be directly involved in the day to day occupational health and safety matters of smaller companies. Lead exposed workers are often seen in primary care clinics or other outpatient facilities for illness or injury care. Additionally, these facilities may be providing contract services and routine medical surveillance for employers. The health effects of lead may not be rec- ognized in these settings unless health care providers are alert to the possibility of both occupational and nonoccupational lead exposure. Though limited, these interactions may provide nurses employed by such facilities the only opportunity to offer quality education to the workers and employers about health and safety matters, and industry specific information related to lead exposure (Gillen, 1996) .
In general, occupational and environmental health nurses can potentially influence work practices through their knowledge of regulations and standards, as well as through their advocacy for worker health and safety (Rogers, 1994) . Occupational and environmental health nurses need to be well informed about lead exposure issues so they in tum can educate workers, employers, and other health care professionals not familiar with the health effects of lead and required forms of protection.
Nurses working in states with an Occupational Blood Lead Registry need to be knowledgeable about the reporting requirements and how a registry functions. Registries are a valuable resource for identifying workers at risk for lead poisoning and for targeting prevention efforts at state and federal levels.
WHICH WORKERS MUST BE MONITORED
Medical surveillance requirements are determined by a worker's exposure to lead in the air, by a worker's BLL, and, in the construction trades, by work involving certain high exposure "trigger tasks." Some industries and jobs in both general industry and construction that may be associated with lead exposure are listed in Table   4 .
The employer must perform personal air sampling if employees are exposed to lead at work. OSHA defines the Action Level (AL) as an airborne lead concentration of 30 micrograms per cubic meter (ug/m''), The AL triggers certain other requirements of the standards. Construction workers performing certain tasks are required to have an initial BLL and ZPP when first assigned to jobs such as sanding, abrasive blasting, torch cutting, welding, or demolition where lead is present. All employees exposed at or above the AL for> 30 days per year must be enrolled in a medical surveillance program provided by the employer.
Air monitoring does not always reflect the actual amount of exposure, particularly when significant exposure occurs through hand to mouth activities, such as eating, drinking, or smoking in the workplace, that contribute to lead ingestion. Routine BLL and ZPP monitoring of lead exposed workers provides important additional information to guide prevention efforts.
BLOOD LEAD LEVELS AND MEDICAL REMOVAL
Under the lead standards, all employees who may be exposed to lead above the Action Level must be offered BLL and ZPP tests at specified, minimum time intervals.
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The required minimum frequency of biological monitoring is summarized in the Schedules for Medical Services (Tables 5-6 ). Construction industry employers must notify their employees in writing of the BLLs within 5 days of receiving the test results . In general industry, written notification is required for BLLs >40 !J.gldL. It is recommended that all employees be notified of their test results.
The physician must recommend to the employer that an employee be removed from lead exposure and enter a medical removal protection (MRP) program if any of the following conditions are met:
General Industry Standard
• A single BLL is~60 !J.gldL, or • An average of the last three BLLs or all BLLs over the previous 6 months (whichever covers a longer time period) is~50 !J.gldL, or • The employee has a "detected medical condition" that places him or her at increased risk of "material impairment to health" from lead exposure. (The OSHA lead standards do not define these terms. Thus, the physician is given the discretion to make such a determination on an individual case basis.)
Construction Industry Standard • A single BLL is~50 ug/dl., or • The employee has a detected medical condition that places him or her at increased risk of material impairment to health from lead exposure (See above) . A physician can remove an employee with a BLL below the specified MRP levels based, on relevant medical findings in individual cases, such as symptoms commonly associated with lead toxicity or pregnancy. Whenever an employee is placed on MRP, the frequency of biological monitoring must be increased to at least once a month. After two consecutive BLLs are ,;;;40!J.gldL,the physician can recommend to the employer that the employee return to the previous work if the employer has taken steps to control lead exposure and the employee's symptoms or any other clinical manifestations of toxicity have resolved. It is recommended these blood tests be at least 1 month apart to allow for mobilization and excretion of the lead burden.
During the time an employee is removed from work with lead by a physician's recommendation, the employee must retain earnings, seniority, and other benefits. The physician can allow an employee, if physically able, to work in an area free of lead exposure while on MRP. The OSHA standards permit a worker on MRP to work in any area where the 8 hour time weighted average (TWA) air lead concentration is <30 ,.i.glm 3 • However, because significant lead exposure can occur even when air lead levels are not elevated (e.g., by hand to mouth ingestion), the supervising physician should carefully review the safety of any lead related work for an employee on MRP. The standards require the employer to continue to pay the employee's usual wage and benefits during the removal period, whether or not the employee is working. If workers' compensation disability benefits are used to pay a Reports signs/symptoms of lead toxicity, desires advice about effects of lead exposure (on reproductive system, child bearing, etc.), has increased risk of material impairment to health due to lead exposure , or has difficulty breathing with respirator use.
Medical Evaluation
Prior to assignment: General and leadspecific history and physical exam with special attention to hematological, neurological (central and peripheral), pulmonary, cardiovascular, gastrointestinal, musculoskeletal, renal, and reproductive systems. Medical clearance to wear respirator, if used-applies to all categories.
Annually (see above)
As soon as MRP initiated (see above)
As soon as possible (see above)
Laboratory Testing
Complete portion of the salary, the employer is responsible for paying the balance. Upon return to work, employees are guaranteed former job status.
MEDICAL EVALUATIONS
The lead standards specify frequency and recommended guidelines for medical screening. Annual medical evaluations are required for all employees with a BLL ;::.40 J,Lg/dL in the prior 12 months. In general industry, medical evaluations are required prior to assignment for all employees entering a work area in which JULY 1998, VOL. 46, NO.7 they may be exposed to lead at or above the Action Level >30 days per year. It is the employer's responsibility to ensure that the medical evaluations are performed. Nonetheless, the physician has a major role to play in carrying out the intent of the standards.
The medical evaluation must include all the elements listed in Tables 5 and 6. The physician may include any other medical tests that are necessary based on sound medical practice. As part of a complete respiratory protection program, federal OSHA requires medical clearance for any worker using a respirator (29 CFR 
Medical Evaluation
Medical clearance to wear respirator, if used -applies to all categories
Same as above
Annually: General and lead specific history and physical exam with special attention to hematological, neurological (central and peripheral), pulmonary, cardiovascular, gastrointestinal, musculoskeletal, renal, and reproductive systems .
Laboratory Testing
Bll and ZPP As deemed appropriate by the physician based on individual case needs.
• 29 CFR §1926.62(d)(2) tpg/dL = micrograms of lead per deciliter of whole blood; pg/m 3 = micrograms of lead per cubic meter of air §MRP is the required removal of an employee from work with lead exposure, with full salary and benefits, until there are two consecutive BBLs of~40 pg/dL and the physician authorizes return to the usual work. §1910.134).
The physician is only permitted to provide the employer with the results of the medical evaluation that relate to the employee's occupational exposure. The employer must forward a copy of the same written information to the employee. The physician should notify the employee directly of any other health conditions that 336 require further evaluation.
In addition to annual requirements, medical evaluations must be performed as soon as possible if any of the following occur:
• An employee develops signs or symptoms commonly associated with lead toxicity, • An employee plans to have children and requests med-ical advice concerning the effects of lead exposure, or • An employee has difficulty breathing while using a respirator. Additionally, the OSHA lead standards state that medical evaluation as appropriate must be provided for an employee either removed from exposure to lead due to increased risk of sustaining "material impairment to health from exposure to lead," or who requires special protections as determined by the physician.
Placement of a worker on MRP is considered a reportable illness. A proposed federal OSHA requirement would make a BLL of~40 J.Lg/dL reportable.ln addition to recording lead exposure cases on the OSHA 200 Injury and Illness Log, physicians may need to file a report to comply with various state laws. For example, in California the physician must file a Doctor's First Report of Injury or Illness within 5 days after initial examination for every employee with an occupational injury or illness (Title 8 CCR §14003).
TREATMENT
The primary therapy for lead poisoning is cessation of exposure. Prophylactic chelation therapy solely to prevent the rise of blood lead levels is a violation of the OSHA lead standards. Prior to diagnostic or therapeutic chelation therapy, workers must be notified in writing as to why they are receiving this therapy.
In adults, the use of chelation therapy should be reserved for those with significant symptoms or signs of toxicity (Table 1 ) and should only be undertaken with strict and skilled clinical supervision. Occasionally, adults may have a very high BLL (e.g., 90 J.Lg/dL) and be asymptomatic. These individuals should be removed from exposure and followed carefully, but chelation therapy may not prove necessary. Levels > 100 J.Lg/dL are usually associated with significant symptoms that may warrant chelation.
Chelation therapy primarily reduces lead in the blood and soft tissues, such as liver and kidney, and not in the generally larger fraction of lead in bone. In individuals with substantial bone lead stores who are chelated, re-equilibration of lead from bone back into blood and soft tissues may result in a rebound effect with a rise in the BLL after an initial drop. Symptoms associated with lead toxicity may recur.
Chelation guidelines are controversial and may change as new agents and information are introduced. Although chelation has been associated with improvement in symptoms and decreased mortality, controlled clinical trials demonstrating efficacy are lacking, and treatment recommendations have been largely empiric (Kosnett, 1992 (Kosnett, , 1994b .
Chelation should be considered only on an individual case basis and in consultation with health care providers knowledgeable about treatment of adult lead poisoning (Royce, 1993) . University based occupational and environmental medicine clinics are a recommended resource.
Major differences exist in the recommended treatment of children and adults. For example, the Centers for JULY 1998, VOL. 46, NO.7 Disease Control and Prevention recommend chelation for all children with BLLs of~45 J.Lg/dL. The chelation challenge test, developed in the 1960s to assess total body burden and amount of chelatable lead, has not been found to be a valid predictor of health effects, or remote or long term lead exposure. Chelatable lead may reflect little of the total body 'burden found in bone (Kosnett, 1994b; Tell, 1992) . Currently, no data exist to indicate that the chelation challenge test can identify individuals who may derive a therapeutic benefit from chelation. A more promising indicator of bone stores, and consequently total lead body burden, is noninvasive x-ray fluorescence (XRF) of the bone (Hu, 1995) .
APPROVED LABS
Blood lead analyses performed under the lead standards must be conducted by laboratories that meet OSHA accuracy requirements in blood lead proficiency testing. A current list of approved laboratories is available from the regional or area office of federal OSHA (U.S. Department of Labor). For more information, the nurse can contact the OSHA Salt Lake City Technical Center, Division of Quality Control, Salt Lake City, Utah (801-487-0073).
CONCLUSION
Lead poisoning is preventable. Medical surveillance is a tool used to identify excessive lead exposure and direct and evaluate exposure reduction efforts. The overall goal is to reduce workers' BLLs to those of the general population. This is best accomplished by limiting lead exposure through proper engineering controls and work practices. It is worth noting that MRP levels were first established in 1977 when the assumed background BLL for the general population was 19 J.Lg/dL (it is now about 3 J.Lg/dL). Therefore, controlling workplace lead exposure to maintain workers' BLLs <20 J.Lg/dL should be feasible. Some physicians have suggested that medical removal and return trigger BLLs be reduced to 20 and 10 J.Lg/dL, respectively (Landrigan, 1991; Silbergeld, 1991) . Employers may need to obtain technical assistance in controlling exposures. By working together, the employer and the clinician can use biomedical information to identify problems and implement improvements in the workplace.
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The "lead standards"established by OSHA for general industry in 1978 and the construction industry in 1993 require employers and clinicians to follow very specific guidelines for protecting lead exposed workers. Depending on the level of exposure, medical surveillance may be legally required.
Lead affects multiple body systems and can cause permanent damage. Low level exposures that in the past were thought safe are now considered hazardous as new information emerges about the toxicity of lead.
Lead poisoning, if undetected, often results in misdiagnosis and costly care. Adults are exposed to lead in many different workplace settings.All clinicians caring for lead exposed workers need to be informed about the health effects of lead, employer and physician responsibilities, and worker rights.
Occupational and environmental health nurses can help identify workers at risk and prevent lead poisoning by education and early intervention through collaboration with the workers, the employer, the company physician, and other health and safety professionals.
